NEW YORK – Ceres Nanosciences announced Monday it has won a $243,000 Phase I Small Business Innovation Research grant from the US Centers for Disease Control and Prevention.
The Manassas, Virginia-based infectious disease testing firm will use the funding to adapt its Nanotrap virus particles to work with portable sequencing tools. These hydrogel nanoparticles house chemical affinity baits, providing an alternative to RNA extraction kits and could be used to build viral pathogen surveillance workflows.